Es wird kein Kindle Gerät benötigt. Laden Sie eine der kostenlosen Kindle Apps herunter und beginnen Sie, Kindle-Bücher auf Ihrem Smartphone, Tablet und Computer zu lesen.

  • Apple
  • Android
  • Windows Phone
  • Android

Geben Sie Ihre Mobiltelefonnummer ein, um die kostenfreie App zu beziehen.

Kindle-Preis: EUR 13,64
inkl. MwSt.

Diese Aktionen werden auf diesen Artikel angewendet:

Einige Angebote können miteinander kombiniert werden, andere nicht. Für mehr Details lesen Sie bitte die Nutzungsbedingungen der jeweiligen Promotion.

An Ihren Kindle oder ein anderes Gerät senden

An Ihren Kindle oder ein anderes Gerät senden

Facebook Twitter Pinterest
The Billion-Dollar Molecule: The Quest for the Perfect Drug von [Werth, Barry]
Anzeige für Kindle-App

The Billion-Dollar Molecule: The Quest for the Perfect Drug Kindle Edition

4.9 von 5 Sternen 8 Kundenrezensionen

Alle Formate und Ausgaben anzeigen Andere Formate und Ausgaben ausblenden
Preis
Neu ab Gebraucht ab
Kindle Edition
"Bitte wiederholen"
EUR 13,64

Harry Potter und das verwunschene Kind
Harry Potter Fans aufgepasst: die deutsche Ausgabe des Skripts zum Theaterstück ist ab dem 24.September erhältlich Jetzt vorbestellen

Produktbeschreibungen

Amazon.de

From test tubes to the Wall Street IPO and beyond, this is the riveting true story of a start-up pharmaceutical company working to create an anti-AIDS drug. Scientifically accurate, yet written with an attention to plot, timing, dialogue, and development of character more characteristic of the best thrillers.

Pressestimmen

Geoffrey Smith Business Week A riveting tale that has more in common with a John Grisham thriller than with tomes on modern science.

John Schwartz The Washington Post The inside skinny...a high stakes tale of adventure and intrigue: Barbarians at the Lab. Werth's work is a gem.

John Travis The Boston Globe Fascinating...gripping...must reading for anyone curious about an industry that promises to revolutionize medical care in the next century.

Produktinformation

  • Format: Kindle Edition
  • Dateigröße: 2063 KB
  • Seitenzahl der Print-Ausgabe: 481 Seiten
  • Verlag: Simon & Schuster; Auflage: Revised ed. (20. August 2013)
  • Verkauf durch: Amazon Media EU S.à r.l.
  • Sprache: Englisch
  • ASIN: B00AK78PTG
  • Text-to-Speech (Vorlesemodus): Nicht aktiviert
  • X-Ray:
  • Word Wise: Aktiviert
  • Verbesserter Schriftsatz: Aktiviert
  • Durchschnittliche Kundenbewertung: 4.9 von 5 Sternen 8 Kundenrezensionen
  • Amazon Bestseller-Rang: #46.134 Bezahlt in Kindle-Shop (Siehe Top 100 Bezahlt in Kindle-Shop)

  •  Ist der Verkauf dieses Produkts für Sie nicht akzeptabel?

Kundenrezensionen

4.9 von 5 Sternen
5 Sterne
7
4 Sterne
1
3 Sterne
0
2 Sterne
0
1 Stern
0
Alle 8 Kundenrezensionen anzeigen
Sagen Sie Ihre Meinung zu diesem Artikel

Top-Kundenrezensionen

Format: Taschenbuch
Working in a small start up biotech company, I found many parallels with the "Vertex Story" and the company I work for. I was able to identify with the pressure of finding a lead drug candidate (though not quite as intense as those Vertex scientists who went to Hell and back), the rallying of all the employees to do the best thing for the company, and hoping that upper management can keep raising the cash to keep us going. I might add that raising money now has become even more challenging with the advent of the Internet and the dot com companies that have taken a huge chunk of the available investment dollars. The story that unfolds in this book is a very good depiction of how difficult it is to find a drug candidate let alone one that will make it all the way through the FDA-required clinical trials. The clinical trials, although outside the scope for this book, are a significant part of getting a drug to the market and present their own set of challenges. A good book to get a pretty good feel of this is HER-2 by Robert Bazell about the road Genentech's Herceptin took before finally receiving FDA approval to treat breast cancer.
Kommentar 2 Personen fanden diese Informationen hilfreich. War diese Rezension für Sie hilfreich? Ja Nein Feedback senden...
Vielen Dank für Ihr Feedback.
Wir konnten Ihre Stimmabgabe leider nicht speichern. Bitte erneut versuchen
Missbrauch melden
Format: Taschenbuch
I first read this book nearly two years ago as research for a novel I was writing. Recently, I turned to it once more to pick up a few terms and found myself reading chapter after chapter!
This non-fiction tale has enough twists and turns and drama to match any thriller on the market. An informative and engaging tale of a pharmaceutical start-up and the people involved. Joshua is interesting enough that the book could have been solely about him, but he isn't the only one. All of the players in this ego-driven mega-drama are interesting on many levels.
Who would I reccomend this book to? Anyone who likes a well-told story. A background in medicine is not needed, and neither is a knowledge of business practices. All you need to enjoy this book is a brain . . . and a night light because you'll be reading this book deep into the night.
Kommentar 2 Personen fanden diese Informationen hilfreich. War diese Rezension für Sie hilfreich? Ja Nein Feedback senden...
Vielen Dank für Ihr Feedback.
Wir konnten Ihre Stimmabgabe leider nicht speichern. Bitte erneut versuchen
Missbrauch melden
Format: Taschenbuch
Barry's Werth spent several years with the scientists and bio-venturers who formed Vertex Pharmaceuticals. The work paid off in an insightful and entertaining book. The Billion Dollar molecule is the holy grail of the researchers in today's pharmaceutical world, and this book shows how they go about attaining it. A remarkably easy book to read even if you don't know a protein from a Springsteen. The reader can find something valuable from all angles. Read it as a science book, a thriller, a business narrative, or a straight novel, you'll find delight here.
Kommentar War diese Rezension für Sie hilfreich? Ja Nein Feedback senden...
Vielen Dank für Ihr Feedback.
Wir konnten Ihre Stimmabgabe leider nicht speichern. Bitte erneut versuchen
Missbrauch melden
Format: Taschenbuch
Barry Werth has managed in this book to capture the essence of the excitement, frustrations, suffering and satisfaction of being in a successful high-tech startup company. Having had unprecedented access to staff at Vertex and its collaborators, he has managed to reconstruct events from all angles. Werth presents his story in a compelling dramatic style, from the heady heights of scientific discovery, to the depths of VC capriciousness.
This book is highly suggested reading in our new startup!
Kommentar War diese Rezension für Sie hilfreich? Ja Nein Feedback senden...
Vielen Dank für Ihr Feedback.
Wir konnten Ihre Stimmabgabe leider nicht speichern. Bitte erneut versuchen
Missbrauch melden
click to open popover